Dara Biosciences launches tablet to treat oral thrush
October 6, 2015 -- Pharmaceutical company Dara BioSciences has launched its Oravig tablet to treat oral thrush for the U.S. oncology and primary care markets.
UNC researcher, biotech firm partner on rapid oral HPV test
October 2, 2015 -- A University of North Carolina (UNC) researcher and a California-based biotechnology company are partnering to create a rapid oral test for HPV.
UbiVac, J &J to develop oral cancer vaccine
September 30, 2015 -- Biotechnology company UbiVac will collaborate with Johnson & Johnson (J&J) Innovation to develop and test an oral cancer vaccine.
Can a laser detect oral cancer?
September 24, 2015 -- Lasers may soon be used to detect oral cancer, replacing invasive biopsies, according to a University of California researcher who has developed a low-cost, simple device using optical coherence tomography to analyze oral lesions.
HPV vaccine could eliminate recurrent oral papillomas
September 23, 2015 -- The HPV vaccine could eliminate recurrent oral squamous cell papillomas, according to a new case report in JAMA Dermatology. An immunocompetent patient with chronic oral warts was cleared of all lesions three months after receiving the quadrivalent HPV vaccine.
Salivary Test for Oral Cancer Now Available
September 23, 2015 -- Oral squamous cell carcinoma (OSCC) is the sixth leading cancer worldwide and the fourth in African-American men. The mortality of this disease has not significantly improved in decades and this is largely due to late diagnosis. A new salivary test can help improve these statistics.
Oral Cancer Foundation announces fall events
September 22, 2015 -- The Oral Cancer Foundation has announced its fall 2015 Walk for Awareness events.
NCI renews $10.9M grant for Pitt cancer research
September 15, 2015 -- The National Cancer Institute (NCI) has renewed a five-year, $10.9 million grant to the University of Pittsburgh (Pitt) Cancer Institute (UPCI) to continue its research on head and neck cancer.
Study: Oral rinse may predict return of HPV-related OPC
September 14, 2015 -- An oral rinse may be able to predict the recurrence of oropharyngeal cancer (OPC) related to human papillomavirus (HPV), according to a new study in JAMA Oncology. The research findings may enable earlier detection of recurrence and new monitoring protocols.
FDA awards $1.1M for immunotherapy research
September 14, 2015 -- The U.S. Food and Drug Administration (FDA) has awarded a $1.1 million grant for research on oropharynx cancer related to human papillomavirus.
Featured Free CE
Oral Cancer Awareness
For Oral Cancer Awareness DrBicuspid is providing the following two courses for Free to our Members. Oral Cancer: The Role of the Dental Professional Part 1 and Part 2
Special Feature
Aspirin can help battle head/neck cancer
Aspirin appears to offer significant protection against head and neck (HNC) cancer, according to a study in the British Journal of Cancer. Regular aspirin use was associated with a 22% reduction in HNC and seems to be particularly effective in preventing laryngeal cancer. Read more.
Dentifrices and Consumer Products
Dry Mouth Products
Tools and Instruments
Oral Cancer Detection